Structure Therapeutics Inc. (GPCR) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 15.28M | -64.42M | -51M | -54.56M | -52.23M | -36.47M | -19.7M | -26.39M | -34.08M | -21.73M | -20.56M | -16.61M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 129.25% | -76.64% | -158.92% | -106.71% | -53.25% | -67.83% | 4.19% | -58.87% | -67.82% | -80.68% | -96.14% | - |
| Net Income | -76.19M | 33M | -65.71M | -61.66M | -46.83M | -36.48M | -33.98M | -26.03M | -26.04M | -24.5M | -23.86M | -23.03M |
| Depreciation & Amortization | 1.22M | 412K | 356K | 291K | 274K | 273K | 265K | 232K | 222K | 72K | 79K | 160.26K |
| Stock-Based Compensation | 0 | 8.07M | 7.5M | 7.51M | 5.92M | 5.83M | 6.02M | 4.2M | 2.74M | 2.1M | 1.86M | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.66M | 0 |
| Other Non-Cash Items | 8.43M | -11.82M | -2.65M | -3.78M | -4.79M | -5.56M | -5.71M | -2.75M | -2.84M | -2.12M | 276K | 14.94K |
| Working Capital Changes | 81.83M | -94.08M | 9.51M | 3.08M | -6.8M | -534K | 13.7M | -2.03M | -8.17M | 2.72M | 2.75M | 6.24M |
| Change in Receivables | 100.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -4.98M | -5.01M | 8.81M | 280K | 686K | -423K | 6.3M | -4.39M | 1.82M | 1.4M | -2.38M | 1.04M |
| Cash from Investing | -498.43M | 56.14M | -49.32M | 48.94M | 34.03M | 33.23M | -189.04M | -204.51M | 1.42M | -180.74M | 30.13M | -68.09M |
| Capital Expenditures | -1.19M | -1.5M | -1.57M | -232K | -314K | -16K | -685K | -427K | -162K | -1.16M | -820K | -189.84K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -30.95K | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 5.09M | 5.16M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30.95K | 0 |
| Cash from Financing | -1.75M | 704.99M | 56.2M | 517K | 809K | 615K | -757K | 514.7M | 702K | 281.63M | 473K | -1.09M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 185.86K | -94.04K |
| Equity Issued (Net) | 834.48K | 708.92M | 57.06M | 519.27K | 966.37K | 0 | 0 | 514.57M | 0 | 300M | 775.82K | -534.05K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -2.58M | -3.93M | -855K | -2.27K | -157.37K | 615K | -757K | 130K | 702K | -18.37M | -488.69K | -462.36K |
| Net Change in Cash | -483.45M | 696.71M | -44.11M | -5.1M | -17.39M | -2.62M | -209.5M | 283.8M | -31.96M | 79.16M | 10.04M | -85.9M |
| Free Cash Flow | 14.09M | -65.91M | -52.57M | -54.79M | -52.54M | -36.48M | -20.38M | -26.82M | -34.24M | -22.89M | -21.38M | -16.8M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 126.82% | -80.66% | -157.93% | -104.29% | -53.45% | -59.42% | 4.66% | -59.61% | -68.61% | -89.18% | -102.57% | - |
| FCF per Share | 0.19 | -1.11 | -0.90 | -0.95 | -0.92 | -0.64 | -0.36 | -0.54 | -0.74 | -0.49 | -0.56 | -0.44 |
| FCF Conversion (FCF/Net Income) | -0.20x | -1.95x | 0.78x | 0.88x | 1.12x | 1.00x | 0.58x | 1.01x | 1.31x | 0.89x | 0.86x | 0.71x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |